The CEO of HeartPoint Global is tackling congenital heart disease with groundbreaking new devices.

Seth Bogner is looking to change the world, one heartbeat at a time. He’s the chairman and CEO of HeartPoint Global, which makes groundbreaking medical devices to treat life-threatening cardiovascular diseases that affect millions of people worldwide every year.

Running this fast-growing juggernaut is not just a job for Seth. It’s a mission. In his article “HeartPoint Global’s ROI Is Survival for Children with Congenital Heart Disease,” he makes that passion very clear. “I’ve been asking for years to have the opportunity to create a business that did something for the world, and how fate works, I, as an investor, founded what ended up becoming HeartPoint,” says the former Wall Street executive, who took the helm of HeartPoint Global in 2016. “Not only that, I love the inventors and founders who were wanting to help kids around the world.”

And many youngsters are in dire need of help. As Seth points out, 90% of children in the world are underserved with cardiac care. HeartPoint Global is looking to change that by addressing the pulmonary hypertension caused by congenital heart disease, as he shares in more detail in the interview. One of its products Seth eagerly talks about is Intellistent, the first and only patented, non-surgical, structural heart system that addresses a variety of life-threatening cardiovascular diseases in pediatric patients at a far more affordable price than other solutions. Once it is rolled out, he expects it to have a massive global impact.

“What national insurer, what insurance company, would not want to go for a $4,000 solution, instead of something that costs hundreds of thousands of dollars, if not a million dollars,” Seth says.

At the moment, HeartPoint Global’s focus is U.S. children and teens from infancy through 19 years old. Making it clear with details and anecdotes throughout the interview that he cares deeply about this issue, Seth notes they are at the center of an epidemic in rising child mortality rates. One cause is congenital heart disease, the most common cause of infant deaths due to birth defects, with 25% of babies born with congenital heart defects passing away before their first birthday, according to the American Academy of Pediatrics. The company is also looking to help adults who can benefit from its products. “It turned out, because of the nature of what we’re doing, we could help a lot more people also in the developed world, also older populations,” Bogner says.

Seth is well aware he has a fiduciary duty to his investors, but he believes it’s possible to combine purpose and profit. His energetic devotion to building the business, he says, comes from his personal spirituality. “I’m a spiritual person, and whether you believe in God or don’t believe in God, or you believe in nature or you believe in anything, you can’t ignore the fact that we’re all part of one system,” Seth says. “And I have my own belief system, sure you do, but I believe that it’s not about just sleeping at night. I think it’s about responsibility. … I think that if enough people in the world start thinking along the lines that we’re discussing today, that the way you feel or the way I feel — that changes the world in a way, just the thought, power of the thought.”

Seth recently spoke with Chris Benguhe, founder and president of the Dave Alexander Center for Social Capital and publisher of the Social Capital Insider, about his work. Learn more about this compassionate Social Capital leader and his capitalistic solution to a life-threatening issue — click on the link below to watch the entire video.